Colorectal Cancer Clinical Trials

A listing of Colorectal Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 20 clinical trials
Anlotinib Combined With mXELIRI as Second-line Treatment of Advanced Colorectal Cancer

combination of anlotinib and mXELIRI in the second-line treatment of patients with advanced colorectal cancer

  • 0 views
  • 12 Sep, 2021
  • 1 location
PD-1 Inhibitor Combined With Bevacizumab and FOLFIRI Regimen in the Second-line Treatment of Advanced Colorectal Cancer

MSI-H is a biomarker for solid tumors benefiting from immunotherapy. Recent clinical studies have confirmed that PD-1 inhibitors have a good effect on MSI-H advanced colorectal cancer for first

  • 0 views
  • 12 Sep, 2021
  • 1 location
A Study of ERAS-007 in Patients With Advanced Gastrointestinal Malignancies

To evaluate the safety and tolerability of escalating doses of ERAS-007 in combination with other cancer therapies in study participants with advanced GI malignancies. To determine the Maximum Tolerated Dose (MTD) and/or Recommended Dose (RD) of ERAS-007 administered in combination with other cancer therapies. To evaluate the antitumor activity of …

  • 0 views
  • 15 Sep, 2021
  • 1 location
A Study to Test Different Doses of BI 1823911 Alone and Combined With Other Medicines in People With Different Types of Advanced Cancer With KRAS Mutation

This study is open to adults with different types of advanced or metastatic cancer (including lung cancer, colorectal cancer, pancreatic cancer, and bile duct cancer). This study is for people

  • 0 views
  • 15 Sep, 2021
  • 4 locations
Clinical Trial Evaluating External Evaluation and Training on the Incomplete Resection (POLIPEVA Study)

Introduction It has been shown that some quality indicators in endoscopy can be improved through educational interventions. There are marked differences in the proportion of incomplete polypectomies among endoscopists. The effectiveness of measures to improve it has not been evaluated. objective The main objective is to evaluate whether a training …

endoscopy
polypectomy
colorectal polyps
cold
colonoscopy
  • 0 views
  • 08 Sep, 2021
  • 1 location
Artificial Intelligence Assists Surgeons' Decision Making

This study will evaluate whether artificial intelligence technique reduces the temporary ileostomy rate in patients with rectal cancer who receive anterior resection.

total mesorectal excision
adenocarcinoma
  • 0 views
  • 17 Sep, 2021
  • 1 location
Capnographic Monitoring in Gastrointestinal Endoscopy for Elderly Patients

Hypoxia is the most common adverse event in gastrointestinal endoscopes sedated with propofol and sufentanil, especially in elderly people. The aim of this randomized study was to determine whether intervention based on additional capnographic monitoring reduces the incidence of hypoxia in gastrointestinal endoscopes procedures for elderly patients.

endoscopy
propofol
  • 0 views
  • 15 Sep, 2021
  • 3 locations
Assessing Effect of Withdrawal Time on Adenoma Detection Rate for Screening Colonoscopy

The investigators' null hypothesis is that a withdrawal time of 9 to 10 minutes is non-inferior to a withdrawal time of 12 minutes or greater. Thus, the goal of this tandem design trial is to compare the additional diagnostic yield (# of missed lesions) for withdrawal times exceeding 10 minutes …

  • 0 views
  • 15 Sep, 2021
  • 1 location
Incorporating ePrognosis for the Encouragement of Smarter Screening for Breast and Colorectal Cancer in Older Adults

This clinical trial assesses the feasibility and acceptability of a smarter screening intervention for breast and colorectal cancer in older adults. This study aims to learn more about how to

cancer
  • 0 views
  • 06 Sep, 2021
  • 1 location
JAB-21822 Activity in Adult Patients With Advanced Solid Tumors Harboring KRAS G12C Mutation

This study is to evaluate the safety and tolerability of JAB-21822 monotherapy and combination therapy in adult participants with advanced solid tumors harboring KRAS G12C mutation.

measurable disease
KRAS
EGFR
cetuximab
  • 0 views
  • 16 Sep, 2021
  • 3 locations